Impact of Day 14 Bone Marrow Biopsy on Re-Induction Decisions and Prediction of a Complete Response in Acute Myeloid Leukemia Cases

BACKGROUND: With acute myeloid leukemia (AML), there are limited data about the accuracy of day 14 bone marrow (BM) biopsies for predicting complete remission as compared to day 28 BM biopsy results. We here aimed to estimate the correlation between, and the diagnostic accuracy of, both approaches....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Asian Pac J Cancer Prev
Hlavní autoři: Alsaleh, Khalid, Aleem, Aamer, Almomen, Abdulkareem, Anjum, Farhan, Alotaibi, Ghazi S
Médium: Artigo
Jazyk:Inglês
Vydáno: West Asia Organization for Cancer Prevention 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5980929/
https://ncbi.nlm.nih.gov/pubmed/29479992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22034/APJCP.2018.19.2.421
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky